Breast cancer is a multifactorial disease, which is clinically defined by hormone receptor (HR) status, e.g., an estrogen receptor-positive (ER+) and/or progesterone-receptor positive (PR+) and human epidermal growth factor receptor 2-positive (HER2+) status [2]. This evidence concerns the gene ESR1 and breast carcinoma.